TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9800052

Group type: EXPERIMENTAL
Intervention: Amlodipine (5-10 mg) once daily
Number of subjects: 132

Group type: COMPARATOR
Intervention: Diltiazem CR (90-120 mg) twice daily
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Both agents
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 132

Group type: COMPARATOR
Intervention: Diltiazem CR
Number of subjects: 132
Study: 8818853

Group type: EXPERIMENTAL
Intervention: Azithromycin (10 mg/kg once daily for 3 days)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Cefaclor (20 mg/kg/day in three divided doses for 10 days)
Number of subjects: 200
Study: 2137666

Group type: EXPERIMENTAL
Intervention: Sustained-release isradipine administered once daily
Number of subjects: 76

Group type: COMPARATOR
Intervention: Immediate-release isradipine administered twice daily
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Sustained-release isradipine
Number of subjects: 76
Study: 7022879

Group type: EXPERIMENTAL
Intervention: Adjunctive antithymocyte globulin (ATG) therapy
Number of subjects: 130

Group type: COMPARATOR
Intervention: Standard antirejection treatment (SAT) of steroid pulsing and local irradiation
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Combined results for patient survival
Number of subjects: 130
Study: 31651529

Group type: EXPERIMENTAL
Intervention: R-dihydroetorphine 12.5 ng/kg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: R-dihydroetorphine 75 ng/kg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: R-dihydroetorphine 125 ng/kg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: R-dihydroetorphine 150 ng/kg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: R-dihydroetorphine
Number of subjects: 20
Study: 28296744

Group type: EXPERIMENTAL
Intervention: CoTOL
Number of subjects: 210

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 210
Study: 25546369

Group type: EXPERIMENTAL
Intervention: Oral solution fasting (50mg)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Tablet fasting (50mg)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Oral solution fed (50mg)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Tablet fed (50mg)
Number of subjects: 36
Study: 24918481

Group type: EXPERIMENTAL
Intervention: Active suction (AS group)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Natural evacuation (NE group)
Number of subjects: 75
Study: 22155024

Group type: EXPERIMENTAL
Intervention: Patient Controlled Analgesia (PCA) methods for acute pain management
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Recruitment strategies including referrals from urgent care and SCD clinics
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Survey of site-specific factors and policies
Number of subjects: 38
Study: 21156060

Group type: EXPERIMENTAL
Intervention: Comprehensive intervention of community mobilization, birth attendant training, and improvement of quality of care in health facilities
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control group (not explicitly defined in the abstract)
Number of subjects: 106
Study: 18054724

Group type: EXPERIMENTAL
Intervention: Acupuncture (n=15)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Acupressure (n=16)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Sham Acupressure (n=16)
Number of subjects: 47
Study: 16267767

Group type: EXPERIMENTAL
Intervention: Praziquantel treatment (early treatment group, n=64)
Number of subjects: 287

Group type: COMPARATOR
Intervention: Delayed treatment (n=66)
Number of subjects: 287

Group type: EXPERIMENTAL
Intervention: Early treatment (n=105)
Number of subjects: 287

Group type: COMPARATOR
Intervention: Delayed treatment (n=122)
Number of subjects: 287
Study: 11925631

Group type: EXPERIMENTAL
Intervention: Free diet group (Group 2)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard diet group (Group 1)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Comparison of bile reflux with intragastric pH
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Linear regression analysis
Number of subjects: 30
Study: 10446081

Group type: COMPARATOR
Intervention: Placebo therapy
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Gemfibrozil therapy
Number of subjects: 265

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 265
Study: 8543715

Group type: EXPERIMENTAL
Intervention: EMDR treatment (3 sessions of 90 minutes each)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Delayed-treatment condition
Number of subjects: 80
Study: 2102432

Group type: EXPERIMENTAL
Intervention: 400 mg Ibuprofen administered directly postoperatively (2nd administration after 6 hours)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ibuprofen taken as required
Number of subjects: 0
Study: 28134

Group type: EXPERIMENTAL
Intervention: Chlorazepate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31707849

Group type: EXPERIMENTAL
Intervention: Evolocumab
Number of subjects: 14298

Group type: COMPARATOR
Intervention: Control (no evolocumab)
Number of subjects: 14298
Study: 31072848

Group type: EXPERIMENTAL
Intervention: Preventive catheter ablation (CA) at the time of ICD implantation
Number of subjects: 208

Group type: COMPARATOR
Intervention: Deferred catheter ablation (CA) after the third appropriate ICD shock for ventricular tachycardia
Number of subjects: 208
Study: 27390153

Group type: EXPERIMENTAL
Intervention: Early provision of ankle-foot orthosis (Week 1)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Delayed provision of ankle-foot orthosis (Week 9)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Early provision of ankle-foot orthosis
Number of subjects: 33
Study: 25833980

Group type: EXPERIMENTAL
Intervention: Lipid-based nutrient supplement (LNS) 20 g/d
Number of subjects: 1057

Group type: COMPARATOR
Intervention: Iron and folic acid (IFA)
Number of subjects: 1057

Group type: COMPARATOR
Intervention: Multiple micronutrient (MMN)
Number of subjects: 1057
Study: 21946544

Group type: EXPERIMENTAL
Intervention: Primary open-angle glaucoma group with ET-1 level of 3.27±1.25 pg/mL
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Normal tension glaucoma group with ET-1 level of 3.12±1.46 pg/mL
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Primary angle-closure glaucoma group with ET-1 level of 2.58±0.22 pg/mL
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group with ET-1 level of 1.53±1.49 pg/mL
Number of subjects: 102
Study: 22315765

Group type: EXPERIMENTAL
Intervention: Midazolam 0.5 mg kg(‐1)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Ketamine 6 mg kg(‐1)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Combination of ketamine 2.5 mg kg(‐1) and midazolam 0.25 mg kg(‐1)
Number of subjects: 90
Study: 19700035

Group type: EXPERIMENTAL
Intervention: Chapatis containing 4 g beta-glucan
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Chapatis containing 8 g beta-glucan
Number of subjects: 8

Group type: COMPARATOR
Intervention: Chapatis containing 2 g beta-glucan
Number of subjects: 8

Group type: COMPARATOR
Intervention: Chapatis containing 6 g beta-glucan
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control chapatis (0 g beta-glucan)
Number of subjects: 8
Study: 17122236

Group type: EXPERIMENTAL
Intervention: Single Shot Spinal (SSS) with 2 mL of 0.5% hyperbaric bupivacaine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Combined Spinal Epidural (CSE) with equivalent dose of hyperbaric bupivacaine
Number of subjects: 40
Study: 14709426

Group type: EXPERIMENTAL
Intervention: Adult-learning model (experimental group)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Traditional lecture-based teaching methods (control group)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Both groups rated self-proficiency
Number of subjects: 150

Group type: COMPARATOR
Intervention: Instructor ratings of student proficiency
Number of subjects: 150
Study: 11930834

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (MP)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (MP) combined with cyclophosphamide (CPH)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 35
Study: 9632030

Group type: EXPERIMENTAL
Intervention: Fluoxetine 20-60 mg plus group psychotherapy
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo plus group psychotherapy
Number of subjects: 47
Study: 9727573

Group type: EXPERIMENTAL
Intervention: ZDV-3TC (200 mg three times daily and 150 mg twice daily)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: d4T-3TC (40 mg and 150 mg, both twice daily)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Indinavir added to both groups if plasma HIV RNA level at week 8 or thereafter was > 500 copies/ml
Number of subjects: 47
Study: 2495147

Group type: EXPERIMENTAL
Intervention: BCAA-TPN (50% BCAA)
Number of subjects: 9
Study: 15907

Group type: EXPERIMENTAL
Intervention: Electrocoagulation
Number of subjects: 299

Group type: COMPARATOR
Intervention: Tubal rings
Number of subjects: 299
Study: 30958388

Group type: EXPERIMENTAL
Intervention: Hazardous cannabis use
Number of subjects: 78

Group type: COMPARATOR
Intervention: Nonhazardous cannabis use
Number of subjects: 78

Group type: COMPARATOR
Intervention: Nonusers of cannabis
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Greater cannabis use severity
Number of subjects: 78
Study: 27388251

Group type: EXPERIMENTAL
Intervention: Nepafenac ophthalmic suspension 0.1%
Number of subjects: 175

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 175
Study: 26123989

Group type: EXPERIMENTAL
Intervention: Oral L-arginine supplementation (10 g/day for 3 or 6 months)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of L-arginine (0.5 g Arg/kg bodyweight for 30 min)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 23616509

Group type: EXPERIMENTAL
Intervention: Isoflavone supplement (rich in daidzein, 60%) providing 94 mg isoflavones daily for 8 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo for 8 weeks
Number of subjects: 30
Study: 19909291

Group type: EXPERIMENTAL
Intervention: Primary Vitrectomy (PV)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Scleral Buckling (SB)
Number of subjects: 0
Study: 19838433

Group type: EXPERIMENTAL
Intervention: Non-stented group (n=55)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Stented group (n=55)
Number of subjects: 110
Study: 16960472

Group type: EXPERIMENTAL
Intervention: Topiramate (TPM) 100 mg/d
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Triptans
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 14716835

Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccination
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control (unvaccinated healthy volunteers)
Number of subjects: 31
Study: 11422095

Group type: EXPERIMENTAL
Intervention: rizatriptan 10 mg
Number of subjects: 4814

Group type: EXPERIMENTAL
Intervention: rizatriptan 5 mg
Number of subjects: 4814

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 4814
Study: 9130215

Group type: EXPERIMENTAL
Intervention: Inpatient treatment according to ASAM criteria
Number of subjects: 292

Group type: COMPARATOR
Intervention: Intensive outpatient treatment according to ASAM criteria
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Inpatient care for cocaine patients who met ASAM criteria
Number of subjects: 292

Group type: COMPARATOR
Intervention: Intensive outpatient treatment for alcohol patients who met ASAM criteria
Number of subjects: 292
Study: 7955941

Group type: EXPERIMENTAL
Intervention: Athletes
Number of subjects: 66

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 66
Study: 2647603

Group type: EXPERIMENTAL
Intervention: Serrapeptase (Aniflazym)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Elevation of the leg, bed rest, with and without the application of ice
Number of subjects: 66
Study: 31755166

Group type: EXPERIMENTAL
Intervention: Heat and moisture exchanger (HME)
Number of subjects: 13

Group type: COMPARATOR
Intervention: No heat and moisture exchanger (without HME)
Number of subjects: 13
Study: 28739540

Group type: EXPERIMENTAL
Intervention: Exercise (weight training and aerobic exercise)
Number of subjects: 351

Group type: EXPERIMENTAL
Intervention: Weight-loss
Number of subjects: 351

Group type: EXPERIMENTAL
Intervention: Exercise and weight-loss
Number of subjects: 351

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 351
Study: 25495353

Group type: COMPARATOR
Intervention: No device (ND)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: EtCO2 detector (DET)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Quantitative EtCO2 detector (CAP)
Number of subjects: 23
Study: 23629524

Group type: EXPERIMENTAL
Intervention: Laparoscopic repair (LR)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Open repair (OR)
Number of subjects: 157
Study: 21521545

Group type: EXPERIMENTAL
Intervention: LcS-fermented milk administered (n 39)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Non-administered group (n 38)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: LcS-fermented milk administered (n 10)
Number of subjects: 77
Study: 18356827

Group type: EXPERIMENTAL
Intervention: Catechin group (576 mg catechins per day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (75 mg catechins per day)
Number of subjects: 40
Study: 16485702

Group type: EXPERIMENTAL
Intervention: Large Bore Syringe
Number of subjects: 128

Group type: COMPARATOR
Intervention: Small Bore Syringe
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Injection over longer times (5, 10, 15, or 20 sec)
Number of subjects: 128
Study: 12399900

Group type: EXPERIMENTAL
Intervention: Endoscopy performed on patients with epigastric tenderness
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Gastroenterology treatment for patients with positive endoscopy findings
Number of subjects: 132
Study: 10720164

Group type: EXPERIMENTAL
Intervention: Rye bread (20% of daily energy)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Wheat bread (20% of daily energy)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Rye bread consumption (in tertiles)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Rye bread and wheat bread
Number of subjects: 40
Study: 8604444

Group type: EXPERIMENTAL
Intervention: Implantable cardioverter defibrillators (ICDs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Antiarrhythmic drugs (sotalol or amiodarone)
Number of subjects: 0
Study: 1394142

Group type: EXPERIMENTAL
Intervention: Tamoxifen (6-36 weeks)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Tamoxifen (3-6 months)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Tamoxifen (12-18 months)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Low-fat diet (20% of total calories) with tamoxifen
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control (no tamoxifen)
Number of subjects: 76
Study: 4048464

Group type: EXPERIMENTAL
Intervention: Baros
Number of subjects: 100

Group type: COMPARATOR
Intervention: E‐Z‐Gas II
Number of subjects: 100
Study: 30654818

Group type: EXPERIMENTAL
Intervention: Food, Fun, and Families (FFF) intervention
Number of subjects: 119

Group type: COMPARATOR
Intervention: Delayed treatment control
Number of subjects: 119
Study: 30067148

Group type: EXPERIMENTAL
Intervention: Previous training in LGB‐TGNC health
Number of subjects: 228
Study: 25883078

Group type: EXPERIMENTAL
Intervention: Irrigated multi-electrode ablation (IMEA)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Radiofrequency point-by-point ablation (RF-PVI)
Number of subjects: 49
Study: 25400470

Group type: EXPERIMENTAL
Intervention: Probiotic drink containing Lactobacillus casei DN 114001
Number of subjects: 258

Group type: COMPARATOR
Intervention: Probiotic drink containing Lactobacillus casei Shirota
Number of subjects: 258
Study: 23007065

Group type: EXPERIMENTAL
Intervention: Branched-chain amino acid supplementation (BCAA) - 50 g total including 20 g BCAA
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Branched-chain amino acid supplementation (BCAA)
Number of subjects: 28
Study: 20591139

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (AET) + usual care
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy (CBT) + usual care
Number of subjects: 75

Group type: COMPARATOR
Intervention: Usual care alone (no therapy or occasional physical therapy)
Number of subjects: 75
Study: 18484357

Group type: EXPERIMENTAL
Intervention: Urinary nucleoside profiling using mass spectrometry
Number of subjects: 113

Group type: COMPARATOR
Intervention: Currently applied breast cancer biomarkers (e.g., CA15‐3)
Number of subjects: 113
Study: 16100154

Group type: EXPERIMENTAL
Intervention: Silver Nitrate (20 mL 0.5%)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Talc Slurry (5 g diluted to 50 mL with saline)
Number of subjects: 60
Study: 12584835

Group type: EXPERIMENTAL
Intervention: Si' an capsule combined Enalapril
Number of subjects: 60

Group type: COMPARATOR
Intervention: Enalapril alone
Number of subjects: 60
Study: 10359467

Group type: EXPERIMENTAL
Intervention: Cortisol treatment (40 mg/d)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Cortisol treatment (160 mg/d)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 7481854

Group type: EXPERIMENTAL
Intervention: Combination of paclitaxel and doxorubicin
Number of subjects: 730

Group type: COMPARATOR
Intervention: Single-agent paclitaxel
Number of subjects: 730

Group type: COMPARATOR
Intervention: Single-agent doxorubicin
Number of subjects: 730

Group type: EXPERIMENTAL
Intervention: Cisplatin and paclitaxel
Number of subjects: 730
Study: 2030196

Group type: EXPERIMENTAL
Intervention: Group cognitive therapy (CT)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Supportive, self‐directed therapy (S/SD)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Focused expressive psychotherapy (FEP)
Number of subjects: 63
Study: 6281451

Group type: EXPERIMENTAL
Intervention: Burned patients
Number of subjects: 36
Study: 31548248

Group type: EXPERIMENTAL
Intervention: Genetically predicted serum 25-hydroxyvitamin D (S-25OHD) levels
Number of subjects: 898130

Group type: EXPERIMENTAL
Intervention: Genetically predicted serum calcium (S-Ca) levels
Number of subjects: 898130

Group type: EXPERIMENTAL
Intervention: Genetically predicted serum parathyroid hormone (S-PTH) levels
Number of subjects: 898130
Study: 28629905

Group type: EXPERIMENTAL
Intervention: Continuing antirheumatic drug therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Withholding antirheumatic drug therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Optimal glucocorticoid management
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Restarting antirheumatic medications post-surgery
Number of subjects: 0
Study: 25347552

Group type: EXPERIMENTAL
Intervention: High oleic sunflower oil (HOSO)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Virgin olive oil (VOO)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Sunflower oil (SO)
Number of subjects: 15
Study: 24385407

Group type: EXPERIMENTAL
Intervention: Enteric-coated aspirin (100-300 mg/day)
Number of subjects: 3378

Group type: COMPARATOR
Intervention: Other antiplatelet drugs
Number of subjects: 3378
Study: 21768516

Group type: EXPERIMENTAL
Intervention: Zidovudine-lamivudine-abacavir (ZDV-3TC-ABC)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Zidovudine-lamivudine-nevirapine (ZDV-3TC-NVP)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Zidovudine (ZDV)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Abacavir (ABC)
Number of subjects: 83
Study: 19387336

Group type: EXPERIMENTAL
Intervention: Interactive Spaced Education (ISE) on hematuria and priapism (HP)
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Interactive Spaced Education (ISE) on staghorn calculi, infertility, and antibiotic use (SIA)
Number of subjects: 480
Study: 17322151

Group type: EXPERIMENTAL
Intervention: Valsartan (80 to 160 mg once or twice daily)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 15095555

Group type: EXPERIMENTAL
Intervention: Intravenous 0.9 mg/kg TPA with TCD monitoring
Number of subjects: 55
Study: 11409475

Group type: EXPERIMENTAL
Intervention: Extra-strong graduated compression stocking
Number of subjects: 95

Group type: COMPARATOR
Intervention: Standard graduated compression stocking
Number of subjects: 95
Study: 9710023

Group type: EXPERIMENTAL
Intervention: 11C-flumazenil (FMZ) PET
Number of subjects: 24
Study: 18173197

Group type: EXPERIMENTAL
Intervention: TFX‐thymomodulin
Number of subjects: 20

Group type: COMPARATOR
Intervention: Radiotherapy only
Number of subjects: 20
Study: 3202084

Group type: EXPERIMENTAL
Intervention: Predictive equations for total adipose-tissue volume based on weight/height
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Predictive equations for visceral adipose-tissue volume based on sagittal diameter of the trunk at the L3-L5 level
Number of subjects: 27
Study: 30550176

Group type: EXPERIMENTAL
Intervention: Butylphthalide with non‐invasive ventilator
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Treatment group of butylphthalide
Number of subjects: 90

Group type: COMPARATOR
Intervention: Non‐invasive ventilator group
Number of subjects: 90
Study: 25881731

Group type: EXPERIMENTAL
Intervention: McGrath MAC video laryngoscope
Number of subjects: 66

Group type: COMPARATOR
Intervention: King Vision video laryngoscope
Number of subjects: 66
Study: 26427036

Group type: EXPERIMENTAL
Intervention: Probiotic tablet containing Streptococcus oralis KJ3, Streptococcus uberis KJ2 and Streptococcus rattus JH145, used twice a day for 12 weeks
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Probiotic tablet
Number of subjects: 48
Study: 23688334

Group type: EXPERIMENTAL
Intervention: BF (breakfast diet)
Number of subjects: 60

Group type: COMPARATOR
Intervention: D (dinner diet)
Number of subjects: 60
Study: 20533245

Group type: EXPERIMENTAL
Intervention: Green tea extract (GTE) supplementation (159 mg/day total catechins)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 18835479

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral treatment (CBT) with integrated emotion-regulation training
Number of subjects: 289

Group type: COMPARATOR
Intervention: Cognitive-behavioral treatment (CBT)
Number of subjects: 289